Medical specialists from Denmark tagged as investigators in clinical trials studying Prostatic Neoplasms
Total 26 results
-
Bodil Ginnerup, MD, PhDSeen in:
- Aarhus, Aarhus N, Aarhus University Hospital
Trials:- NCT05767307 (Sub-Investigator)
Conditions: -
Christine Vestergaard MadsenSeen in:
- Syddanmark, Vejle, Vejle Sygehus
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Gedske DaugaardSeen in:
- Copenhagen, Rigshospitalet University Hospital
- Hovedstade, Copenhagen, Rigshospitalet
Trials:- NCT02375204 (Principal Investigator)
- NCT05288166 (Principal Investigator)
Conditions:- Seminoma;
- Teratoma;
- Choriocarcinoma;
- Germinoma;
- Germ Cell Tumor;
- Yolk Sac Tumor;
- Mixed Germ Cell Tumor;
- Childhood Teratoma;
- Malignant Germ Cell Neoplasm;
- Extragonadal Seminoma;
- Non-seminomatous Germ Cell Tumor;
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Henriette Lindberg, M.D.Seen in:
- Herlev, Herlev Hospital
Trials:- NCT02102477 (Sub-Investigator)
Conditions: -
Henrik Jacobsen, M.D.Seen in:
- Herlev, Herlev Hospital
Trials:- NCT02102477 (Principal Investigator)
Conditions: -
Jacob Fredsøe, PhDSeen in:
- Aarhus, Aarhus N, Aarhus University Hospital
Trials:- NCT05767307 (Sub-Investigator)
Conditions: -
Karina D Sørensen, PhDSeen in:
- Aarhus, Aarhus N, Aarhus University Hospital
Trials:- NCT05767307 (Principal Investigator)
Conditions: -
Klaus BrassoSeen in:
- Copenhagen, Rigshopsitalet Department urology
- Copenhagen, Rigshospitalet
Trials:- NCT02914873 (Principal Investigator)
- NCT02102477 (Principal Investigator)
Conditions: -
Lars Lund, M.D.Seen in:
- Odense, Odense University Hospital
Trials:- NCT02102477 (Sub-Investigator)
Conditions: -
Lars P Boesen, MDSeen in:
- Hellerup, Herlev & Gentofte University Hospital
Trials:- NCT05767307 (Principal Investigator)
Conditions: -
Lise Bentzen, M.D.Seen in:
- Aarhus, Aarhus University Hospital
Trials:- NCT02102477 (Principal Investigator)
Conditions: -
Mads HA Poulsen, MD, PhDSeen in:
- Odense, Odense University Hospital
Trials:- NCT05767307 (Principal Investigator)
Conditions: -
Mads Hvid, M.D.Seen in:
- Odense, Odense University Hospital
Trials:- NCT02102477 (Sub-Investigator)
Conditions: -
Martin Mortensen, M.D.Seen in:
- Aarhus, Aarhus University Hospital
Trials:- NCT02102477 (Sub-Investigator)
Conditions: -
Mette Moe Kempel, M.D.Seen in:
- Aalborg, Aalborg University Hospital
Trials:- NCT02102477 (Sub-Investigator)
Conditions: -
Michael Borre, MD, PhDSeen in:
- Aarhus, Aarhus N, Aarhus University Hospital
Trials:- NCT05767307 (Principal Investigator)
Conditions: -
Nicklas J Spindler, MDSeen in:
- Capital Region, Herlev, Department of Oncology, Copenhagen University Hospital Herlev and Gentofte Hospital
Trials:- NCT05655715 (Sub-Investigator)
-
Niels Harving, M.D.Seen in:
- Aalborg, Aalborg University Hospital
Trials:- NCT02102477 (Principal Investigator)
Conditions: -
Per KongstedSeen in:
- Hovedstade, Copenhagen, Herlev and Gentofte Hospital
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Peter B ØstergrenSeen in:
- Herlev, Herlev and Gentofte Hospital
Trials:- NCT04086290 (Principal Investigator)
Conditions: -
Peter M Meidahl Petersen, M.D ass profSeen in:
- Copenhagen, Rigshospitalet, Region h, Department Oncology
Trials:- NCT02102477 (Principal Investigator)
Conditions: -
Redas TrepiakasSeen in:
- Sjælland, Næstved, Næstved Sygehus
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Rikke HL Eefsen, MD, PhDSeen in:
- Capital Region, Herlev, Department of Oncology, Copenhagen University Hospital Herlev and Gentofte Hospital
Trials:- NCT05655715 (Principal Investigator)
-
Steinbjørn Hansen, M.D.Seen in:
- Odense, Odense University Hospital
Trials:- NCT02102477 (Principal Investigator)
Conditions: -
Vibeke Løgager, MDSeen in:
- Hellerup, Herlev & Gentofte University Hospital
Trials:- NCT05767307 (Sub-Investigator)
Conditions:
Clinical Trials on Prostatic Neoplasms
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterActive, not recruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer MetastaticUnited States